Transparent Graphene Neural Electrode Arrays for Optogenetic Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current neural interface devices, such as micro-ECoG arrays, are limited by opaque metallic conductive materials that prevent direct optogenetic stimulation and imaging at the electrode-tissue interface, hindering the correlation of tissue response with recorded signals.
Innovation Solution
Development of a micro-electrode array with transparent, biocompatible graphene electrode sites on a dielectric substrate, allowing for optogenetic stimulation and imaging through the electrode array, while maintaining electrical conductivity and mechanical flexibility for tissue implantation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If opaque metallic conductive materials are used in micro-ECoG arrays, then electrical conductivity is ensured, but optogenetic stimulation and imaging at the electrode-tissue interface are prevented
Solution Approach 1:
The patent changes the material parameter from traditional opaque metals to transparent conducting oxides (TCOs) such as indium tin oxide (ITO), indium zinc oxide (IZO), and zinc oxide (ZnO). This parameter change enables light transmission across UV, visible, and IR wavelengths while maintaining electrical conductivity, thereby resolving the contradiction between optical transparency and electrical conductivity for optogenetic applications
Solution Approach 2:
The patent employs composite material structures combining transparent conducting oxide layers with flexible polymer substrates (e.g., PDMS, parylene) and conductive traces. This composite approach achieves both optical transparency for imaging/stimulation and electrical conductivity for neural signal recording, while adding mechanical flexibility for chronic implantation
2Illumination intensity
If ITO is used as transparent conductor, then transparency is achieved, but brittleness and high-temperature processing requirements arise
Solution Approach 1:
The patent deposits TCO layers as thin films (typically 50-200 nm thickness) on flexible polymer substrates, transforming the brittle oxide into a flexible composite structure. The thin film geometry combined with the flexible substrate enables bending and conformal attachment to curved brain surfaces, resolving the brittleness issue while maintaining transparency
Solution Approach 2:
By combining TCO thin films with flexible polymers like PDMS and parylene, the patent creates composite materials that exhibit both optical transparency and mechanical flexibility. The polymer substrate provides flexibility and biocompatibility, while the TCO layer provides transparency and conductivity
3Illumination intensity
If ITO is used for transparent micro-ECoG, then transparency is improved, but process-dependent transparency limitations in UV and IR wavelength ranges occur
Solution Approach 1:
The patent develops TCO-based electrode arrays that function across multiple wavelength ranges (UV, visible, and IR) to support diverse optogenetic opsins and fluorescent imaging modalities. The universal transparency across the spectrum enables a single device to perform multiple optical functions, resolving the wavelength range limitation
4Measurement precision
If traditional opaque electrodes are used, then electrical signal recording is achieved, but correlation of tissue response with recorded signals is hindered
Solution Approach 1:
The patent merges electrophysiological recording and optical imaging capabilities into a single integrated transparent micro-ECoG device. The transparent TCO electrodes simultaneously record electrical neural signals and allow optical imaging of underlying tissue, enabling direct correlation between tissue response and recorded signals without information loss
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables simultaneous recording of neural signals and optogenetic stimulation, as well as in vivo imaging, with improved transparency and reduced tissue impedance, comparable to traditional platinum-based arrays, while maintaining signal clarity and stability.
Implementation Method 1
the electrode sites comprising one or more sheets of electrically conductive graphene
Implementation Method 2
The electrode sites and the portion of the substrate on which the electrode sites are disposed are transparent in at least a portion of the wavelength range from about 300 to about 2000 nm
Data Source
AI summary
Devices for detecting electrical activity in electrically active biological tissues and methods for using the devices are provided. The devices include an electrode array that is configured for implantation on electrically active biological tissue. The electrode array comprises a plurality of electrode sites comprising one or more layers of transparent, electrically conductive graphene disposed on a transparent substrate.